Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 100204
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.100204
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.100204
Figure 2 Serum lipid, triglyceride-glucose index, and atherosclerotic index in patients with colorectal cancer and healthy participants.
A: Serum lipids including total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C); B: Triglyceride-glucose (TyG) index and atherosclerotic index (AI) in all research subjects; C: Serum lipids; D: TyG index and AI in male subjects; E and F: Serum lipids; TyG index, and AI in female subjects. Data are presented as the mean ± standard deviation and analyzed by the Student’s t-test. aP < 0.05; bP < 0.01; cP < 0.001. CRC: Colorectal cancer.
- Citation: Hu RH, Yan DY, Zhang KH, Zhang D, Cui XM, Jiang XH, Zhang S. Lipid levels and insulin resistance markers in patients with colorectal cancer: Propensity score matching analysis. World J Gastrointest Oncol 2025; 17(1): 100204
- URL: https://www.wjgnet.com/1948-5204/full/v17/i1/100204.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i1.100204